A pedestrian walks by the Pinterest headquarters on April 09, 2019 in San Francisco.<\/p>\n
Justin Sullivan | Getty Images<\/p>\n<\/div>\n<\/div>\n<\/div>\n
Check out the companies making the biggest moves before the bell:<\/em><\/p>\n Bank of America<\/a><\/span><\/span><\/span> \u2014 Bank of America added 0.4% in the premarket after beating top and bottom line estimates for the second quarter.\u00a0BofA’s results were helped by more profitable lending, boosted by higher interest rates.<\/p>\n Bank of N.Y. Mellon<\/a><\/span><\/span><\/span> \u2014 The bank reported better-than-expected profit and revenue for the second quarter. Like BofA, Bank of N.Y. Mellon benefited from the impact of higher interest rates. However, the stock fell more than 1%<\/p>\n PNC Financial<\/a><\/span><\/span><\/span> \u2014 PNC shares fell 2.7% in the premarket after posting lower-than-expected quarterly revenue, even as earnings beat forecasts.\u00a0Deposits and net interest income both fell at PNC.<\/p>\n Verizon<\/a><\/span><\/span><\/span>, AT&T<\/a><\/span><\/span><\/span> \u2014 Verizon gained 1% in premarket trading, while AT&T rose 0.7%. Both have been tumbling in recent days, with AT&T hitting its lowest level since 1993 Monday and Verizon dipping to its lowest since 2010.\u00a0Analysts have been concerned about potential liability from miles of lead-encased cables across the U.S. \u00a0<\/p>\n Masimo<\/a><\/span><\/span><\/span> \u2014 Masimo plummeted 28% in the premarket after the medical device maker forecast lower than expected sales for its second quarter, as hospitals cut back on equipment spending amid increased personnel costs.<\/p>\n Novartis<\/a><\/span><\/span><\/span> \u2014 Novartis jumped 2.9% in premarket action after the drug maker raised its full-year outlook on strong pharmaceutical sales.\u00a0Novartis also said its planned spin-off of generic drug division Sandoz would take place early in the fourth quarter.<\/p>\n